Columbus Circle Investors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
– Sell
-26,309
Closed -$2.02M – 242
2017
Q3
$2.02M Sell
26,309
-12,613
-32% -$953K 0.03% 223
2017
Q2
$2.91M Buy
38,922
+5,542
+17% +$393K 0.05% 188
2017
Q1
$2.22M Sell
33,380
-13,098
-28% -$873K 0.03% 218
2016
Q4
$3.03M Sell
46,478
-99,231
-68% -$6.44M 0.04% 207
2016
Q3
$10.3M Buy
+145,709
New +$10.6M 0.11% 156
2015
Q4
– Sell
-138,840
Closed -$11.4M – 300
2015
Q3
$11.4M Sell
138,840
-113,433
-45% -$10.1M 0.09% 181
2015
Q2
$22.2M Sell
252,273
-4,484
-2% -$411K 0.16% 157
2015
Q1
$22.7M Buy
256,757
+106,949
+71% +$9.49M 0.15% 143
2014
Q4
$12.4M Buy
+149,808
New +$12.4M 0.09% 192
2014
Q2
– Sell
-318,837
Closed -$24.3M – 293
2014
Q1
$24.3M Buy
318,837
+188,089
+144% +$13.7M 0.16% 140
2013
Q4
$9.42M Sell
130,748
-146,672
-53% -$10.2M 0.06% 221
2013
Q3
$19.1M Buy
277,420
+190,214
+218% +$12.6M 0.14% 174
2013
Q2
$5.53M Buy
+87,206
New +$5.67M 0.04% 222

Other funds holding NVS

Columbus Circle Investors's NVS Position: Q4 2017 in Review

Columbus Circle Investors sold out of Novartis (NVS) in Q4 2017, closing a stake of 26,309 shares — an estimated $2.02M sold.

Columbus Circle Investors first reported a position in NVS in Q2 2013 and held it in 13 quarters. The position peaked at $24.3M in Q1 2014. 1,007 funds tracked by Wall St. Rank hold NVS as of Q4 2017.

  • Columbus Circle Investors reported no remaining Novartis position as of Q4 2017 after selling out during the quarter.
  • Columbus Circle Investors sold 26,309 Novartis shares in Q4 2017, an estimated $2.02M.
  • Columbus Circle Investors first reported a position in Novartis in Q2 2013 and held it in 13 quarters.
  • Columbus Circle Investors's Novartis position peaked at $24.3M in Q1 2014.
  • 1,007 funds tracked by Wall St. Rank held Novartis as of Q4 2017.

Based on Columbus Circle Investors's 13F filing for Q4 2017, filed 2 Feb 2018.